Experimental autoimmune panencephalitis and uveoretinitis transferred to the lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia

Journal of Experimental Medicine

Volumn 180, Issue 3, 1994, Pages 817-830

  Kojirna, Kirnikazu ^a   Berger, Thomas ^b,c   Lassmann, Hans ^b,d   Hinze Selch, Dunja ^a   Zhang, Yiping ^a   Gehrrnann, Jochen ^a   Reske, Konrad ^e   Wekerle, Hartrnut ^a   Linington, Christopher ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b Neurological Institute   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIGEN; CALCIUM BINDING PROTEIN; CD4 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LYMPHOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; PROTEIN S 100; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFER; MACROGLIA; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; T LYMPHOCYTE; UVEORETINITIS;

AMINO ACID SEQUENCE; ANIMAL; ASTROCYTES; CELL LINE; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; EPITOPES; IMMUNOTHERAPY, ADOPTIVE; MACROPHAGE ACTIVATION; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RETINITIS; S100 PROTEINS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; UVEITIS;

EID: 0027990803     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.180.3.817     Document Type: Article

References (59)

1. Wekerle, H., C. Linington, H. Lassmann, and R. Meyermann. 1986. Cellular immune reactivity within the CNS. Trends Neu-rosci. 9:271.
2. Hickey, W.F., B.L. Hsu, and H. Kimura. 1991. T lymphocytes entry into the central nervous system. J. Neurosci. Res. 28:254.
3. Fontana, A., W. Fierz, and H. Wekerle. 1984. Astrocytes present myelin basic protein to encephalitogenic T cell lines. Nature (Lond.). 307:273.
4. Fierz, W., B. Endler, K. Reske, H. Wekerle, and A. Fontana. 1985. Astrocytes as antigen presenting cells. I. Induction of la antigen expression on astrocytes by T cells via immune interferon and its effects on antigen presentation. J. Immunol. 134:3785.
5. McCarron, R.M., O. Kempski, M. Spatz, and D.E. McFarlin. 1985. Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J. Immunol. 134:3100.
6. Ben-Nun, A., H. Wekerle, and I.R. Cohen. 1981. The rapid isolation of clonable antigen-specific T lymphocytes capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:195.
7. Schluesener, H.J., and H. Wekerle. 1985. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135:3128.
8. Cohen, I.R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today. 13:490.
9. Arnold, B., G. Schönrich, and G.J. Hämmerling. 1993. Multiple levels of peripheral tolerance. Immunol. Today. 14:12.
10. Chluba, J., C. Steeg, A. Becker, H. Wekerle, andJ.T. Epplen. 1989. T cell receptor β chain usage in myelin basic protein-specific rat T lymphocytes. Eur. J. Immunol. 19:279.
11. Urban, J.L., V. Kumar, D.H. Kono, C. Gomez, S.J. Horvath, J. Clayton, D.G. Ando, E.E. Sercarz, and L. Hood. 1988. Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell. 54:577.
12. Burns, F.R., X. Li, N. Shen, H. Offner, Y.K. Chou, A.A. Vandenbark, and E. Heber-Katz. 1989. Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V a and V β chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J. Exp. Med. 169:27.
13. Gold, D.P., M. Vainiene, B. Celnik, S. Wiley, C. Gibbs, G.A. Hashim, A.A. Vandenbark, and H. Offner. 1992. Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor Vβ expression predominates in spinal cord infiltrating T cells. J. Immunol. 148:1712.
14. Acha-Orbea, H., D.J. Mitchell, L. Timmermann, D.C. Wraith, G.S. Tausch, M.K. Waldor, S.S. Zamvil, H.O. McDevitt, and L. Steinman. 1988. Limited heterogeneity of T cell receptors from T lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell. 54:263.
15. Owhashi, M., and E. Heber-Katz. 1988. Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody against a shared idiotype on rat T cell receptors for myelin basic protein. J. Exp. Med. 168:2153.
16. Zaller, D.M., G. Osman, O. Kanagawa, and L. Hood. 1990. Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor Vβ-specific antibodies.J. Exp Med. 171:1943.
17. Vandenbark, A.A., G. Hashim, and H. Offner. 1989. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (Lond.). 341:541.
18. Howell, M.D., S.T. Winters, T. Olee, H.C. Powell, D.J. Carlo, and S.W. Brostoff. 1989. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science (Wash. DC). 246:668.
19. Kuwano, R., H. Usui, T. Maeda, T. Fukui, N. Yamanari, E. Ohtsuka, M. Ikehara, and Y. Takahashi. 1984. Molecular cloning and the complete nucleotide sequence of cDNA to mRNA for S-100 protein of rat brain. Nucleic Acids Res. 12:7455.
20. Jensen, R., D.R. Marshak, C. Anderson, T.J. Lukas, and D.M. Watterson. 1985. Characterization of human brain S100 protein fraction: amino acid sequence of S100β. J. Neurochem. 45:700.
21. Moore, B.W. 1965. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19:739.
22. Cocchia, D. 1981. Immunocytochemical localization of S-100 protein in the brain of adult rat. Cell Tiss. Res. 214:529.
23. Kondo, H., H. Takahashi, and Y. Takahashi. 1984. Immuno-histochemical study of S-100 protein in the postnatal development of Müller cells and astrocytes in the rat retina. Cell Tiss. Res. 238:503.
24. Kato, K., T. Nakajima, Y. Ishiguro, and M. Tenhoshi-Maru. 1982. Sensitive enzyme immunoassay for S-100 protein: determination in human cerebrospinal fluid. Biomed. Res. 3:24.
25. Shashoua, V.E., G.W. Hesse, and B.W. Moore. 1984. Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J. Neurochem. 42:1536.
26. Matthews, W.B. 1991. In MacAlpine’s Multiple Sclerosis. W.B. Matthews, A. Compston, I.V. Allen, and C.N. Martyn, editors. Churchill Livingstone, Edinburgh/London/Melbourne/New York. 122-124.
27. Hünig, T., H.-J. Wallny, J.K. Hartley, A. Lawetzky, and G. Tiefenthaler. 1989. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J. Exp. Med. 169:73.
28. Torres-Nagel, N.E., D.P. Gold, and T. Hünig. 1993. Identification of rat TCR Vβ8.2, 8.5, and 10 gene products by monoclonal antibodies. Immunogenetics. 37:305.
29. Takeya, M., L. Hsaio, and K. Takahashi. 1987. A new monoclonal antibody, TRPM3, binds specifically to certain rat macrophage populations: immunohistochemical and immunoelec-tron microscopic analysis. J. Leucocyte Biology. 41:187.
30. Dijkstra, C.D., E.A. Döpp, P. Joling, and G. Kraal. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies. Immunology. 54:589.
31. Gehrmann, J., and G.W. Kreutzberg. 1991. Characterization of two new monoclonal antibodies directed against rat microglia. J. Comp. Neurol. 313:409.
32. Pette, M., K. Fujita, B. Kitze, J.N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1770.
33. Linington, C., S. Izumo, M. Suzuki, K. Uyemura, R. Meyermann, and H. Wekerle. 1984. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J. Immunol. 133:1946.
34. Ikeda, H., J. Trowsdale, and I. Saito. 1988. Mulcos: a vector for amplification and simultaneous expression of two foreign genes in mammalian cells. Gene. 71:19.
35. Syha-Jedelhauser, J., U. Wendling, and K. Reske. 1991. Complete nucleotide sequence of cDNA for the class II RT1.Bβchain of the Lewis rat. Biochim. Biophys. Acta. 1089:414.
36. Syha, J., W. Henkes, and K. Reske. 1989, Complete cDNA sequence coding for the MHC class II RT1.B a chain of the Lewis rat. Nucleic Acids Res. 17:3985.
37. Linington, C., T. Berger, L. Perry, S. Werth, D. Hinze-Selch, Y. Zhang, H. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin-oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364.
38. Linington, C., M. Webb, and P.L. Woodhams. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6:387.
39. Vass, K., H. Lassmann, H. Wekerle, and H.M. Wisniewski. 1986. The distribution of la antigens in the lesions of rat acute experimental allergic encephalomyelitis. Acta. Neuropathol. 70:149.
40. Sun, D., and H. Wekerle. 1986. Iα-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature (Lond.). 320:70.
41. Schluesener, H.J., R.A. Sobel, C. Linington, and H.L. Weiner. 1987. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139:4016.
42. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443.
43. Hickey, W.F., N.K. Gonatas, H. Kimura, and D.B. Wilson. 1983. Identification and quantitation of T lymphocyte subsets found in the spinal cord of the Lewis rat during acute experimental allergic encephalomyelitis. J. Immunol. 131:2805.
44. Matsumoto, Y, and M. Fujiwara. 1988. Adoptively transferred experimental allergic encephalomyelitis in chimeric rats: identification of transferred cells in the lesions of the central nervous system. Immunology. 65:23.
45. Kondo, H., T. Iwanaga, and T. Nakajima. 1983. An immuno-cytochemical study of the localization of S-100 protein in the retina of rats. Cell Tiss. Res. 231:527.
46. Lassmann, H. 1983. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Springer Verlag, Berlin. 176 pp.
47. Weber, W.E.J., and W.A. Buurman. 1988. In vitro functional blocking of myelin basic protein-specific cytolytic human T lymphocyte clones by immunosuppressive drugs and monoclonal antibodies. J. Neuroimmunol. 22:1.
48. McCarron, R.M., M. Racke, M. Spatz, and D.E. McFarlin. 1991. Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephalitogenic T lymphocytes. J. Immunol. 147:503.
49. Brosnan, C.F., M.B. Bornstein, and B.R. Bloom. 1981. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. J. Immunol. 126:614.
50. Huitinga, I., N. Van Rooijen, C.J.A. de Groot, B.M.J. Uitde-haag, and C.D. Dijkstra. 1990. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172:1025.
51. Shaw, P.J., N.M. Smith, P.G. Inca, and D. Bates. 1987. Chronic periphlebitis retinae in multiple sclerosis. A histological study. J. Neurol. Sei. 77:147.
52. Lucarelli, M.J., J.S. Pepose, A.C. Arnold, and R.Y. Foos. 1991. Immunopathological features of retinal lesions in multiple sclerosis. Ophthalmology. 98:1652.
53. Tschabitscher, H. 1958. Die klinischen und experimentellen Forschungen der multiplen Sklerosen. Wien Z. Nervenheilkunde. 14:381.
54. Bammer, H.G., A. Hofman, and R. Zick. 1965. Aderhautentzündungen bei multipler Sklerose und die sogenannte Uveoen-zephalomeningitis. Dtsch. Z. Nervenheilkunde. 187:300.
55. Berger, B.C., and I.H. Leopold. 1968. The incidence of uveitis in multiple sclerosis. Am. J. Opthalmology. 62:540.
56. Lightman, S., W.I. McDonald, A.C. Bird, D.A. Francis, A. Hoskins, J.R. Batchelor, and A.M. Halliday. 1987. Retinal nervous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain. 110:405.
57. McDonald, W.I., and D. Barnes. 1989. Lessons from magnetic resonance imaging in multiple sclerosis. Trends Neurosci. 12:376.
58. Barnes, D., P.M.G. Munro, B.D. Youl, J.W. Prineas, and W.I. McDonald. 1991. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain. 114:1271.
59. Sedgwick, J., S.W. Brostoff, and D.W. Mason. 1987. Experimental allergic encephalomyelitis in the absence of classical delayed-type hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptorpositive cells infiltrating the central nervous system. J. Exp Med. 165:1058.